Prof. Dr. Michael N. Hall

Torpedo Pharmaceuticals AG’s Mission is to set a New Standard in Cancer Therapy with Innovative Radiopharmaceuticals

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Torqur AG Presents Interim Phase 2 Clinical Trial Results at American Academy of Dermatology